The influence of purulence on ciliary and cough transport in bronchiectasis

Joana Tambascio1, Hugo Celso Dutra de Souza, José Antonio Baddini Martinez

  • 1Physiotherapy Department, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

Respiratory Care
|May 16, 2013
PubMed
Abstract

Insights

Respiratory secretions in bronchiectasis patients show impaired mucus transport and higher contact angles, especially in purulent samples. These findings highlight poor mucus clearance in lung disease, aiding treatment planning.

Area of Science:

  • Pulmonary Medicine
  • Respiratory Physiology
  • Biomaterials Science

Background:

  • Bronchiectasis is characterized by respiratory colonization and infection, altering mucus from mucoid to purulent.
  • Mucus purulence correlates with structural, rheological, and transport properties.
  • Understanding mucus transport is crucial for managing bronchiectasis.

Purpose of the Study:

  • To compare the transport properties of mucoid and purulent respiratory secretions in bronchiectasis patients.
  • To evaluate mucus transport in bronchiectasis patients versus healthy individuals.
  • To identify key differences in mucus properties related to appearance and disease state.

Main Methods:

  • Utilized a simulated cough machine to assess mucociliary transport and contact angle.
  • Analyzed 32 mucoid and 19 purulent samples from bronchiectasis patients.
  • Included 21 control samples from subjects without lung disease.

Main Results:

  • Mucociliary transport was significantly lower in bronchiectasis patients (mucoid and purulent) compared to controls.
  • Purulent samples exhibited reduced mucus displacement during simulated cough (7.57 cm) versus mucoid (23 cm) and control (34 cm) samples.
  • Purulent secretions had a higher contact angle (25°) than mucoid (17°) and control (10°) samples, indicating poorer wetting properties.

Conclusions:

  • Respiratory secretions in bronchiectasis patients demonstrate impaired mucociliary transport, reduced cough clearance, and increased contact angles.
  • These transport deficits are more pronounced in purulent secretions.
  • This classification aids therapists in treatment planning and researchers in subject group homogeneity.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...